...
首页> 外文期刊>Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur? Transfusionsmedizin und Immunham?atologie >Acute Hemolytic Transfusion Reaction due to Anti-P1: A Case Report and Review of Institutional Experience
【24h】

Acute Hemolytic Transfusion Reaction due to Anti-P1: A Case Report and Review of Institutional Experience

机译:抗P1引起的急性溶血输血反应:案例报告和体制经验审查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Here we report a case of acute hemolytic transfusion reaction (HTR) due to anti-P1 and review our institutional database for prevalence of anti-P1 antibodies and frequency of anti-P1-mediated HTR. Anti-P1 antibodies, reported to be present in up to two-thirds of P-2 individuals, are usually clinically insignificant. However, rare cases of acute HTR due to anti-P1 are reported. Case Report: We report the clinical and laboratory features of a mild acute HTR due to an IgM anti-P1 not detected by a routinely used antibody screening method. We reviewed our institutional database to investigate prevalence of anti-P1 antibodies identified in our patient population and frequency of HTR in patients with anti-P1. Results: Analysis of RBC transfusion recipient data over the 10-year period from 2006 to 2015 showed prevalence of anti-P1 identified in our laboratory of 174 per 100,000 individuals. Frequency of HTR in patients with anti-P1 identified in our laboratory over a 10-year period was 1 in 1,429 RBC transfusions (0.07%). Conclusion: Our reported case of HTR mediated by IgM anti-P1 reactive at 37 degrees C confirms the potential of antibody screening methods designed to detect IgG antibodies to miss rare clinically significant IgM antibodies.
机译:背景:在这里,我们报告了由于抗P1引起的急性溶血输血反应(HTR)的情况,并审查我们的制度数据库抗P1抗体和抗P1介导的HTR频率的患病率。据报道的抗P1抗体在最多三分之二的P-2个体中,通常是临床上微不足道的。然而,报告了由于抗P1引起的急性急性疾病病例。案例报告:我们报告了由于常规使用的抗体筛选方法未检测到的IgM抗P1,请报告轻度急性HTR的临床和实验室特征。我们审查了我们的制度数据库,以研究抗P1患者患者患者患者人群和HTR频率中鉴定的抗P1抗体的患病率。结果:2006年至2015年的10年期间RBC输血受体数据分析了我们100,000人174人在我们的实验室中确定的抗P1患病率。在我们的实验室中鉴定的抗P1患者频率超过10年期的患者为1,429个RBC输血(0.07%)。结论:我们报告的HTR介导的IgM抗P1在37摄氏度反应介导的HTR确认抗体筛选方法的潜力,设计用于检测IgG抗体以错过罕见的临床显着的IgM抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号